Onconetix (ONCO) Current Assets (2021 - 2026)
Onconetix (ONCO) posted quarterly Current Assets of $4.3 million for Q1 2026, up 78.86% year-over-year from $2.4 million in Q1 2025, and down 28.64% quarter-over-quarter from $6.1 million in Q4 2025.
Onconetix (ONCO) Current Assets (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Current Assets for 6 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 78.86% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 78.86% YoY), while the FY2025 annual figure was $6.1 million, up 538.43% from the prior year.
- Current Assets retreated to $4.3 million in Q1 2026 per ONCO's latest filing, from $6.1 million in the prior quarter.
- Across five years, Current Assets topped out at $30.1 million in Q3 2022 and bottomed at $930531.0 in Q2 2025.
- Historically, Current Assets has averaged $10.2 million across 5 years, with a median of $6.1 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets jumped 754.41% — and 2024, when it plunged 89.02%.
- Onconetix's Current Assets stood at $26.3 million in 2022, then tumbled by 77.77% to $5.8 million in 2023, then sank by 83.72% to $950267.0 in 2024, then surged by 538.43% to $6.1 million in 2025, then retreated by 28.64% to $4.3 million in 2026.
- Business Quant data shows ONCO's Current Assets at $4.3 million in Q1 2026, $6.1 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.52 Mn |
| Mar 31, 2026 | 4.33 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 930,531.00 |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 950,267.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 6.29 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 11.41 Mn |
| Mar 31, 2023 | 22.47 Mn |
| Dec 31, 2022 | 26.26 Mn |
| Sep 30, 2022 | 30.05 Mn |
| Jun 30, 2022 | 23.51 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 3.07 Mn |